MapLight Therapeutics, Inc. MPLT
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -229.83M | -199.48M | -161.15M | -102.83M | -- |
| Total Depreciation and Amortization | 585.00K | 574.00K | 578.00K | 632.00K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 51.09M | 44.16M | 35.27M | 1.04M | -- |
| Change in Net Operating Assets | 3.49M | -9.02M | -12.84M | -11.64M | -- |
| Cash from Operations | -174.67M | -163.77M | -138.14M | -112.80M | -- |
| Capital Expenditure | -453.00K | -497.00K | -473.00K | -203.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -249.98M | -293.20M | -322.73M | -48.06M | -- |
| Cash from Investing | -250.43M | -293.70M | -323.21M | -48.26M | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 276.74M | 276.65M | 276.00M | 134.00K | -- |
| Repurchase of Common Stock | -7.50M | -7.50M | -- | -- | -- |
| Issuance of Preferred Stock | 198.87M | 198.87M | 198.87M | 198.87M | -- |
| Repurchase of Preferred Stock | -30.00K | -30.00K | -30.00K | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.81M | -4.97M | -5.02M | -1.14M | -- |
| Cash from Financing | 463.26M | 463.02M | 469.82M | 197.86M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.17M | 5.55M | 8.48M | 36.80M | -- |